| Estabelecimento de condições ideais de preparo de nanossistemas por nanoprecipitação visando transposição para microfluídica. |
|
2021 |
| 'Low-Cost Microfluidic Device To Produce Biodegradable Polymeric Nanosystems For Drug Delivery' |
|
2021 |
| Particle design of antileishmanial transchalcone by super critical CO2 technology. |
|
2016 |
| Intralesional treatments with retinol or retinoic acid are effective against murine Leishmania amazonensis infection |
|
2014 |
| Sublingual vaccination with LaAg and LACK-DNA leads to increased expression of tolerogenic cytokines and protection against cutaneous leishmaniasis in BALB/c mice |
|
2014 |
| Encapsulation in lipid core nanocapsules (LNC) improves the topical efficacy of chalcone CH8 in cutaneous leishmaniasis |
|
2014 |
| Association with nanoencapsulated retinoic acid stimulates local regulatory T cell production and improves the efficacy of intranasal LaAg vaccine against murine Leishmania amazonensis infection. |
|
2013 |
| Adjuvant effect of retinoic acid in the intranasal LaAg vaccine effective against cutaneous leishmaniasis. |
|
2012 |
| The immunogenicity mechanism induced in cervical lymph nodes by the LACK DNA intranasal vaccine effective against murine leishmaniasis |
|
2012 |
| The adjuvant retinoic acid improves the antileishmanial LaAg intranasal vaccine efficacy and increases the CD4+ Foxp3+ population in the nasal mucosa. |
|
2012 |
| Dietary Vitamin A / retinoic acid modulates the efficacy of an antileishmanial oral vaccine. |
|
2011 |
| Mucosal Vaccines for Systemic Leishmaniasis. |
|
2010 |
| Safety assessment and use of glyceraldehyde-reticulated chitosan microparticles to improve the efficacy os the intranasal LACK-DNA vaccine against cutaneous leishmaniasis. |
|
2009 |
| Oral tratment of murine cutaneous leishmaniasis with a nitrated chalcone. |
|
2009 |
| Incorporation of a nitrated chalcone confers increased elasticity and skin permeability to non-peguilated liposomes with increased topical drug efficacy against cutaneous leishmaniasis. |
|
2009 |
| In Vitro Rheological Analysis to Evaluate Elasticity of Nanoparticles for Percutaneous Drug Delivery. |
|
2009 |
| "Vaccination by nasal route with extracelluler serine peptidases fraction of Leishmania amazonensis induced protection against Leishmania amazonensis protection against murine leishmaniasis" |
|
2009 |
| An intranasal DNA vaccine for visceral leishmaniasis that is systemically expressed and improved with microparticles |
|
2008 |
| Role of intestinal microbiota in the efficacy of an oral antileishmanial vaccine using germ-free mice. |
|
2008 |
| "Influence of retinol on the effectiveness of the oral LaAg vaccine against cutaneous leishmaniasis." |
|
2008 |
| Chitosan microparticles as potential carriers of an antileishmanial lack dna intranasal vaccine. |
|
2007 |
| . Pre-clinical studies of acute toxicity and allergenicity of glyceraldehyde- reticulated chitosan microparticles for intranasal drug and vaccine delivery. |
|
2007 |
| Safety testing in nanocosmetics: studies of allergenicity of poly- caprolactone nanocapsules with benzophenone-3 |
|
2007 |
| Transgenic plants: an alternative for leishmaniasis vaccination? |
|
2007 |
| Antileishmanial LACK-DNA loaded in glyceraldehyde-crosslinked microparticles of chitosan for intranasal vaccination. |
|
2007 |
| The mucosa as a strategic route for antileishmanial vaccine delivery. |
|
2007 |
| Ausência de receptor P2X7 altera perfil inicial da infecção por Leishmania amazonensis e a migração de células para o sítio de Infecção in vivo. |
|
2007 |
| Macroalgas produtoras de moléculas ativas contra a Leishmaniose. |
|
2007 |
| ATP oxidado diminui a internalização de Leishmania amazonensis em macrófagos e atua como agente anti-leishmania em animais C57BL/6 P2X7R+/+ e P2X7 -/-. |
|
2007 |
| The pro-anaphylactic effect of TNF-alfa is independent of its TNFR1 receptor. |
|
2007 |
| The antianaphylactic efect of the partitioned aqueous extract of Kalanchoe pinnata and the flavonoid quercitrin. |
|
2007 |
| ?Changes in lipid metabolism by a natural chalcone and its nitro-substituted synthetic analogue |
|
2007 |
| PAMAM dendrimers as controlled drug release systems to increase the activity of an antileishmanial chalcone. " |
|
2007 |
| P2 receptors: role in host defence against intracellular microorganisms. |
|
2006 |
| Tratamento oral com extrato aquoso de Kalanchoe pinnata protege camundongos BALB/ c contra a leishmaniose visceral. |
|
2006 |
| Efeito antianafilático do extrato aquoso de Kalanchoe pinnata em camundongos. |
|
2006 |
| Potencial Fitoterapêutico de Kalanchoe pinnata (Crassulaceae) no Tratamento da Leishmaniose. |
|
2006 |
| The purinergic receptor (P2X7R) plays a role in macrophage phagocytosis and may be involved in the establishment of L. amazonensis infection. |
|
2006 |
| Stimulation of growth concomitant with decreased infectivity of Leishmania amazonensis by ATP |
|
2006 |
| Intranasal immunization with a particulated Leishmania antigen protects BALB/c mice against visceral leishmaniasis. |
|
2006 |
| Edible vaccines: a promising alternative for leishmaniasis? |
|
2006 |
| Soluble serine proteases from L. amazonensis as disease-promoting components of the intramuscular LaAg vaccine. |
|
2006 |
| Chitosan microparticles as potential carriers of an antileishmanial LACK DNA intranasal vaccine. |
|
2006 |
| Chitosan microparticles as a delivery system for mucosal vaccines against leishmaniasis: pré-clinical studies of acute toxicity and allergenicity. |
|
2006 |
| New synthetic naphthoquinones that are highly inhibitory for Leishmania amazonensis. |
|
2006 |
| Antileishmanial chalcones with increased in vitro activity against African trypanososmes. |
|
2006 |
| Importância das serino proteases na vacinação contra a leishmaniose cutânea murina. |
|
2006 |
| Pre-clinical studies of acute toxicity and allergenicity of chitosan microspheres as a delivery system for antileishmanial mucosal vaccines. |
|
2006 |
| Intranasal delivery of naked DNA encoding the LACK antigen promotes systemic mRNA tissue expression and protects mice against visceral leishmaniasis. |
|
2006 |
| Intranasal vaccination with leishmanial antigens as an effective prophylactic measure against visceral leishmaniasis. |
|
2006 |
| Spray-dried chitosan microspheres as carriers of LACK-DNA intranasal vaccine against leishmaniasis. |
|
2006 |
| Pre-clinical studies of acute toxicity and allergenicity of chitosan microspheres as a delivery system for antileishmanial mucosal vaccines |
|
2006 |
| The Possible Involvement of P2X7 Receptor in the Establishment of Leishmania amazonensis infection. |
|
2006 |
| Dendrimers as carriers of antileishmanial drugs. |
|
2005 |
| The enhanced protectiveness of an intranasal leishmanial vaccine after encapsulation in neutral liposomes is associated with immunomodulation of mucosal and peripheral lymphoid tissues. |
|
2005 |
| Comparative study of acute toxicity and allergenicity of poly-hydroxybutyrate-valerate (PHB-HV) and poly- (lactide-co-glycolide) microparticles. |
|
2005 |
| The antileishmanial effect of ATP is associated with increased macrophage membrane permeability but not cell lysis. |
|
2005 |
| Effective mucosal vaccination against murine leishmaniasis. |
|
2005 |
| The disease-promoting effect of parenteral vaccination of mice with Leishmania amazonensis antigens is due to increased TGF-beta production. |
|
2005 |
| Antimony(v)-guanosine nanosystem: physicochemical characterization and evaluation in experimental model of leishmaniasis. |
|
2005 |
| PAMAM dendrimers as carriers of antileishmanial drugs. |
|
2005 |
| Comparative study of acute toxicity and allergenicity of poly-hydroxybutirate-valerate (PHB-HV) and poly-(lactide-co-glycolide) microparticles. |
|
2005 |
| Modulação da resposta ao cálcio intracelular induzida por nucleotídeos em macrófagos infectados com Leishmania amazonensis. |
|
2005 |
| Modulação da carga parasitária na infecção por Leishmania amazonensis mediada por nucleotídeos extracelulares. |
|
2005 |
| Suppresive effect of hyperbaric oxygen on the development of Leishmania amazonensis-induced lesions in susceptible mice. |
|
2005 |
| Immunological evaluation of attenuated leishmania amazonensis antigens. |
|
2005 |
| Parenteral vaccination with aprotinin agarose fractions of Leishmania amazonesis. |
|
2005 |
| Intranasal immunization with LACK-DNA promotes systemic tecidual mRNA expression and protects BALB/c mice against L. Chagasi infection. |
|
2005 |
| Therapeutic action of extracellular nucleotides on cutaneous leishmaniasis. |
|
2005 |
| The antileishmanial activity of the aqueous extract of a monoclonal Kalanchoe pinnata specimen. |
|
2005 |
| Efficacy of an intranasally administered vaccine containing fractions of L. amazonensis antigen against cutaneous leishmaniasis. |
|
2005 |
| Efficacy of an intranasally administered vaccine containing L. donovani antigens against cutaneous leishmaniasis. |
|
2005 |
| Effective mucosal vaccination against cutaneous leishmaniasis. |
|
2005 |
| Poly-Amidoamine (PAMAM) dendrimers as carriers of antileishmanial drugs. |
|
2005 |
| A role for P2X7receptor in leishmaniasis. |
|
2005 |
| Selective antileishmanial activity of a new synthetic naphthoquinone. |
|
2005 |
| Modulação da resposta ao calcio intracellular induzida por nucleotídeos em macrófagos infectados com Leishmania amazonensis. |
|
2005 |
| Inovação no tratamento de leishmaniose tegumentar murina: uso de dendrímeros PAMAM como carreadores de drogas. |
|
2004 |
| Identificação da quercitrina como principal flavonóide com atividade anti-leishmania no extrato de Kalanchoe pinnata. |
|
2004 |
| Papel do IFN-g no controle da infecção experimental com Leishmania amazonensis. |
|
2004 |
| Ativação do receptor P2X7 como estratégia terapêutica na leishmaniose e análise da susceptibilidade da célula infectada ao ATP. |
|
2004 |
| Modulation of anaphylactic shock in TNFR1 (p55) knock out mice. |
|
2004 |
| Use of particulated systems for nasal vaccination against cutaneous leishmaniasis. |
|
2004 |
| Efficacy of an intranasally administered vaccine containing L. donovani antigen against cutaneous leishmaniasis. |
|
2004 |
| Leishmania amazonensis and Leishmania braziliensis display differential capacity to induce T cell anergy which is associated with soluble molecules. |
|
2004 |
| Protective nasal vaccination against cutaneous leishmaniasis with hsp65 DNA-loaded microspheres. |
|
2003 |
| Cissampelos sympodialis Eichl. (Menispemaceae): oral treatment induces a Th1-skewed cytokine production in actively sensitized mice. |
|
2003 |
| TGF- beta-associated aggravation of leishmaniasis by a leishvacin-like vaccine in mice |
|
2003 |
| The mucosa as a strategic route for antileishmanial vaccine delivery. |
|
2003 |
| Effective intranasal vaccination against leishmaniasis using DNA-hsp65 encapsulated into TDM-loaded PLGA microspheres. |
|
2003 |
| Oral delivery of meglumine antimoniate using beta-cyclodextrin for the treatment of leishmaniasis. |
|
2003 |
| Enhanced protection against experimental cutaneous leishmaniasis using an intranasal vaccine encapsulated in liposomes. |
|
2003 |
| The long-lasting protection conferred by mucosal immunization against murine leishmaniasis |
|
2003 |
| Therapeutic action of ATP on cutaneous leishmaniasis. |
|
2003 |
| Oral delivery of meglumine antimoniate using beta-cyclodextrin for the treatment of leishmaniasis. |
|
2003 |
| A new synthetic chalcone with increased activity and selectivity against murine cutaneous leishmaniasis. |
|
2003 |
| TGF-beta and T cell apoptosis as immunosuppressive mechanism of Leishmania amazonensis antigen. |
|
2003 |
| Nasal vaccination with hsp65 DNA-loaded microspheres induces IFN-gamma and protects mice against leishmaniasis. |
|
2003 |
| Mucosal Vaccination with DNA encoding LACK parasite antigen protects mice against murine leishmaniasis. |
|
2002 |
| Anti-allergic property of Kalanchoe pinnata and associated down-modulation of cytokines in a murine model of anaphylactic shock. |
|
2002 |
| The role of TGF-b in the aggravation of infection of BALB/c mice vaccinated with Leishmania amazonensis lysate. |
|
2002 |
| The role of sterol biosynthesis inhibition on the activity of the natural chalcone dmc against Leishmania, Trypanosoma cruzi, Trypanosoma brucei and Candida spp. |
|
2002 |
| Estudo comparativo dos processos de cultivo e extração de Kalanchoe pinnata visando sua atividade inibidora de linfócitos. |
|
2002 |
| Oral immunization: A new strategy for protection against leishmaniasis. |
|
2001 |
| T suppressive components in L. amazonensis . |
|
2001 |
| Inhibition of sterol synthesis of L. amazonensis by a natural chalcone |
|
2001 |
| O extrato aquoso de Kalanchoe pinnata pode vir a ser uma nova substância na profilaxia de asma brônquica? |
|
2001 |
| Efeito do extrato aquoso de Kalanchoe pinnata na lesão pulmonar aguda induzida por lipopolissacarídeo de E. coli. |
|
2001 |
| Efeito do extrato de Kalanchoe pinnata na hiperreatividade brônquica. |
|
2001 |
| Mecanismos terapêuticos do Kalanchoe pinnata na leishmaniose: ativação da NO sintase e imunomodulação seletiva. |
|
2001 |
| Leishmanicidal activity of plants from Rio de Janeiro State |
|
2001 |
| Further insights into the use of GFP-transfected Leishmania for determination of parasite growth in vitro and in vivo. |
|
2001 |
| Mucosal immunization by oral or nasal routes protect mice against murine leishmaniasis. |
|
2001 |
| The role of TGF-b in the suppressive mechanisms of antigens from different leishmania species |
|
2001 |
| Particulate systems for targeting drugs and vaccines against leishmaniasis. |
|
2001 |
| Efeitos do extrato de Kalanchoe pinnata na mecânica respiratória de camundongos com hiperreatividade brônquica. |
|
2000 |
| Uso do extrato aquoso de Kalanchoe pinnata na proteção contra o choque anafilático em camundongos. |
|
2000 |
| Inibição da síntese de esteróis de Leishmania amazonensis pela 2' 6'-diidroxi-4'-metoxichalcona extraida de Piper aduncum. |
|
2000 |
| Treatment of cutaneous leishmaniasis with Kalanchoe pinnata: experimental and clinical data. |
|
2000 |
| Kalanchoe pinnata extract protects mice against anaphylatic shock induced by ovalbumin. |
|
2000 |
| The leishmanicidal mechanism of 2' 6´dihydroxy-4'-methoxychalcone involves the inhibition of parasite sterol synthesis. |
|
2000 |
| Antigen presenting cells are implicated in the anergy induced by Leishmania amazonensis antigens in BALB/c mice. |
|
2000 |
| Treatment of an Amazonian case of cutaneous leishmaniasis with Kalanchoe pinnata: toxicological and therapeutical data |
|
2000 |
| Oral versus subcutaneous immunization with leishmanial Ag encapsulated in microspheres - a new estrategy for protection in murine leishmaniasis |
|
2000 |
| The Involvement of P2Z/P2X7 receptors in inflammatory diseases. In: 1o International Workshop on Nucleotides and Their Receptors in the Immune System |
|
2000 |
| Enhanced Macrophage Permeabilization by ATP upon Leishmania Infection. |
|
2000 |
| Leishmanicidal activity and ultrastructural changes induced by sulphur synthetic neolignan analogues |
|
1999 |
| The improved antileishmanial activity of 2'-6'-dihydroxy-4'-methoxychalcone after encapsulation in poly (D,L-lactide) nanoparticles may be due to its intracellular targetting in macrophages. |
|
1999 |
| Popular medicinal plants used in Brazil as a source of immunosuppressive, antiviral, antiinflammatory and antiparasitary substances. |
|
1999 |
| Natural Products for the treatment of leishmaniasis |
|
1999 |
| Proposta estrutural para um flavonol 5-hidroxi-3'4'dimetoxi triglicosilado isolado da fração imunossupressora de Kalanchoe gastonis bonneri |
|
1999 |
| Leishmanial infection enhances ATP-induced permeabilization of macrophages |
|
1999 |
| Use of fluorescent leishmania for faster quantitation of parasite growth in vitro and in vivo |
|
1999 |
| Suppressed production of cytokines and T cell proliferation may be due to apoptosis induced by Leishmania amazonensis antigens. |
|
1999 |
| Searching T cell inhibitors in Leishmania amazonensis |
|
1999 |
| Oral immunization with leishmanial antigens delays the onset of infection with L. amazonensis |
|
1999 |
| Aqueous extract of Kalanchoe pinnata plant up-regulates TH1 cytokines in normal and Leishmania-infected mice |
|
1999 |
| Fração Apolar Isolada do Extrato Aquoso de Folhas de Kalanchoe Pinnata (Crassulaceae) Com Atividade Inibidora da Proliferação de Linfócitos. |
|
1998 |
| Síntese de Neolignanas Sulfuradas Com Atividade Antileishmania. |
|
1998 |
| Incorporation Into Poly (D, L -Lactide) Nanospheres Improves The Antileishmanial Action Of A Piper Aduncum Chalcone. |
|
1998 |
| Flavona e Flavonóis Isolados do Extrato Etanólico de Folhas de K. Pinnata. Fesbe. |
|
1998 |
| Modo de Ação e Potencialização da Atividade Leishmanicida de Uma Chalcona Isolada de Piper Aduncum. |
|
1998 |
| Ácidos Graxos da Planta Kalanchoe Pinnata São Responsáveis Pela Sua Atividade Imunossupressora. |
|
1998 |
| Fracionamento do Extrato da Planta Kalanchoe Pinnata Guiado Pela Atividade Imunossupressora e Anti-Leishmania. |
|
1998 |
| Atividade Leishmanicida e Alterações Ultraestruturais Induzidas Por Análogos Sulfurados de Neolignanas de Virola Surinamensis. |
|
1998 |
| Immunosupressive Activity Of Kalanchoe Pinnata In Leishmaniasis Is Related To Nitric Oxide Production And Apoptosis |
|
1998 |
| Leishmanicidal Activity And Ultrastructural Changes Induced By Sulphur Synthetic Neolignan Analogues. |
|
1998 |
| Oral Immunization With Leishmanial Antigens Encapsulated In Microspheres Preferentially Induce Ifn-* In L. Amazonensis -Infected Balb/C Mice. |
|
1998 |
| The T Cell Suppression Induced By Leishmania Amazonensis Antigens May Be Due To Apoptosis. |
|
1998 |
| A Chalcone Isolated From The Plant Piper Aduncum Is Selectively Toxic For Leishmania |
|
1997 |
| The Effectiveness Of Oral Kalanchoe Pinnata Treatment Is Related To Nitric Oxide Production. |
|
1997 |
| Efeito da 2', 6'-Diidroximetoxichalcona Encapsulada Em Nanoesferas Sobre A Leishmaniose Cutânea Experimental. |
|
1997 |
| Obtenção de Uma Fração Apolar do Extrato da Planta Kalanchoe Pinnata Rica Em Substâncias Seletivamente Tóxicas Para Leishmania. |
|
1997 |
| Enhancement Of A Plant-Derived Chalcone By Entrapment In Polymeric Nanospheres. |
|
1997 |
| Chemical Isolation Of An Apolar Antileishmanial And Lymphocyte- Suppressive Substances Present In The Plant Kalanchoe Pinnata. |
|
1997 |
| Oral immunization with leishmanial antigens induce a TH2-type phenotype in C57Bl/6 mice upon infection with Leishmania amazonensis |
|
1997 |
| A Chalcone isolated from the plant Piper aduncum is selectively toxic for Leishmania. |
|
1997 |
| Efeito Leishmanicida da 2', 6'- Diidroxi-4'-Metoxichalcona Isolada de Piper Aduncum. |
|
1996 |
| Reversão do Efeito Protetor da Planta Kalanchoe Na Leishmaniose Com Antagonista do Oxido Nitrico. |
|
1996 |
| Fitoquímica e Atividade Leishmanicida de Espécies de Piperaceae. |
|
1996 |
| Atividade Leishmanicida de Triterpenóides de Pourouma Guianensis. |
|
1996 |
| Activity Of A Pure Chalcone Isolated From Piper Aduncum (Piperaceae) On Leishmania Amazonensis. |
|
1996 |
| The Effectiveness Of Oral Kalanchoe Pinnata Treatment In Murine Leishmaniasis Is Reversed By A Nitric Oxide Inhibitor And Is Accompanied By Increased Il-2 Production. |
|
1996 |
| Lack Of Effect Of Extracellular Atp On The Induced Nitric Oxide Production And Leishmanicidal Activity Of Mouse Peritoneal Macrophages. |
|
1996 |
| Does Oral Immunization Induce Anergy In Cutaneous Leishmaniasis? |
|
1996 |
| Antileishmanial Effect Of A Pure Chalcone Isolated From Piper Aduncum (Piperaceae). |
|
1996 |
| Activity Of A Sulphur Synthetic Neolignan Analogue On Leishmania Amazonensis. |
|
1996 |
| Phytochemical Investigation Of Piper Aduncum. |
|
1996 |
| A flavonoi-rich fraction from the plant Kalanchoe pinnata may be responsible for its protective effect in leishmaniasis. |
|
1996 |
| A role for oligoclonally activated gamma-delta TCR+ IEL in adoptive transfer of inhibition of skin graft rejection in mice. |
|
1995 |
| Oligiclonal expansion of gamma delta TCR+ cells which adoptively transfer inhibition of skin graft rejection in mice after oral immunization. |
|
1995 |
| Plantas brasileiras com atividade leishmanicida: I-Moraceae. |
|
1995 |
| Produção de citocinas TH2 e regulação da rejeição de enxertos por células g/d TCR+ |
|
1995 |
| Kalanchoe flavonoids as possible immunosuppressive and antileishmanial agents. |
|
1995 |
| Modulação da resposta T por flavonoides e terpenos de Kalanchoe |
|
1995 |
| Effectiveness of oral treatment with Kalanchoe pinnata in murine cutaneous leishmaniasis. |
|
1994 |
| Antileishmanial effect of several plant extracts. |
|
1994 |
| Toxicological analysis of an antileishmanial plant extract |
|
1994 |
| Effect Of Kalanchoe Pinnata Leaf Extract On The Production Of Nitric Oxide By Leishmania-Infected Macrophages And Perforin By Cytolytic T Cells |
|
1993 |
| Kalanchoe Leaf Extract Impairs Presentation Of Leishmanial Antigens By Macrophages |
|
1993 |
| Immunological Changes Induced By A Protective Medicinal Plant In Leishmaniasis |
|
1993 |
| Use Of The Limiting Dilution Assay To Assess The Eficacy Of Kalanchoe And Glucantime Treatment In Murine Leishmaniasis |
|
1993 |
| Ativacao da Producao de Oxido Nitrico e Atividade Leishmanicida de Macrofagos Pelo Extrato de Kalanchoe Pinnata. |
|
1993 |
| Estimulacao da Producao de Producao de Perforina Por Linfocitos Citotoxicos Por K. Pinnata. |
|
1993 |
| Isolation of patuletin acetyl-rhamnosides from Kalanchoe brazieliensis |
|
1993 |
| Therapeutic Effect Of Kalanchoe Pinnata Leaf Extract In Experimental Cutaneous Leishmaniasis |
|
1992 |
| The Direct Effect Of Kalanchoe On Leishmania |
|
1992 |
| Treatment Of Experimental Cutaneous Leishmaniasis With Kalanchoe Leaf Extract |
|
1992 |
| Histopathologic Study Of Murine Leishmaniotic Lesions After Parenteral Treatment With Kalanchoe Leaf Extract |
|
1992 |
| The Effect Of Ultraviolet-B Radiation On The Immune Responses In Experimental Cutaneous Leishmaniasis |
|
1992 |
| Acao do Extrato Aquoso de Kalanchoe Pinnata Sobre O Parasita Leishmania. I. Estudo In Vivo |
|
1992 |
| Atividade Imunomoduladora de Plantas Medicinais Brasileiras |
|
1992 |
| Acao do Extrato Aquoso de Kalanchoe Pinnata Sobre O Parasita Leishmania. Ii. Estudos In Vitro |
|
1992 |
| Immunomodulatory Activity of Brazilian Medicinal Plants |
|
1992 |
| Acao Imunomoduladora da Planta Kalanchoe (Saiao) Em Camundongos. |
|
1992 |
| Leishmania-Specific Th1 And Th2 Helper T Cells Are Activated By Different Antigen Presenting Cells. |
|
1991 |
| Macrophages And B Cells Induce Distinct Leishmania-Reactive T Cells. |
|
1991 |
| Action Of Calcitonin And Gm-Csf On Experimental Cutaneous Leishmaniasis |
|
1991 |
| Expansion Of Different Leishmania-Specific T Cell Subsets By Macrophages And B Cells |
|
1991 |
| Mecanismos de Susceptibilidade e Resistencia Na Leishmaniose |
|
1991 |
| Macrophages and B lymphocytes as accessory cells in leishmaniasis |
|
1990 |
